Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-08
2005-02-08
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S064000
Reexamination Certificate
active
06852727
ABSTRACT:
Benzimidazo[4,5-f]isoquinolinone derivatives are inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases.
REFERENCES:
James E. Thompson, et al.,Bioorganic&Medicinal Chemistry Letters, vol. 12, pp. 1219-1223, (2002).
Cubbon Rose M.
Cummings Richard T.
Goulet Joung L.
Hong Xingfang
Sinclair Peter J.
Merck & Co. , Inc.
Owens Amelia A.
Rose David L.
Yang Mollie M.
LandOfFree
Benzimisazo[4,5-f]isoquinolinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimisazo[4,5-f]isoquinolinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimisazo[4,5-f]isoquinolinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3458271